Drug Markets/Alfuzosin Hcl

Alfuzosin Hcl

1 NDC across 1 manufacturer|0 Generic,1 Brand

Alfuzosin Hcl is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $26 million on Alfuzosin Hcl across 1.1 million claims for 310,000 beneficiaries.

Alfuzosin Hcl is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $18.33 to $18.33 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$18.33 – $18.33

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ALFUZOSIN HCL

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
UROXATRAL 10 MG TABLET
$18.3338
per EA
—

Frequently Asked Questions

What is Alfuzosin Hcl used to treat?

Alfuzosin Hcl is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Alfuzosin Hcl?

In 2024, Medicare Part D spent $26 million on Alfuzosin Hcl across 1.1 million claims for 310,000 beneficiaries.

How many Alfuzosin Hcl products are on the market?

The Alfuzosin Hcl drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Alfuzosin Hcl?

NADAC reference prices for Alfuzosin Hcl range from $18.3338 to $18.3338 per EA.

Which manufacturers make Alfuzosin Hcl?

1 manufacturer lists Alfuzosin Hcl in NADAC. Ranked by number of NDCs, the largest are Advanz Pharma (US) Corp. (1).